N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide

C20H32N4O4 — CID 54640055

IUPACN-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide
SMILESCN(C)CCCNC(=O)C[C@H]1CC[C@@H](NC(=O)Cc2cccnc2)[C@H](CO)O1
InChIInChI=1S/C20H32N4O4/c1-24(2)10-4-9-22-19(26)12-16-6-7-17(18(14-25)28-16)23-20(27)11-15-5-3-8-21-13-15/h3,5,8,13,16-18,25H,4,6-7,9-12,14H2,1-2H3,(H,22,26)(H,23,27)/t16-,17-,18+/m1/s1
InChIKeyIHGRXRHOBYYXJU-KURKYZTESA-N
MW392.50 g/mol
LogP0.11
Rot. Bonds10

About N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide

N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide (PubChem CID 54640055) has the molecular formula C20H32N4O4 and a molecular weight of 392.50 g/mol. Its IUPAC name is N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide.

Molecular Properties

Compound NameN-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide
PubChem CID54640055
Molecular FormulaC20H32N4O4
Molecular Weight392.50 g/mol
Exact Mass392.24
IUPAC NameN-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide
SMILESCN(C)CCCNC(=O)C[C@H]1CC[C@@H](NC(=O)Cc2cccnc2)[C@H](CO)O1
InChIInChI=1S/C20H32N4O4/c1-24(2)10-4-9-22-19(26)12-16-6-7-17(18(14-25)28-16)23-20(27)11-15-5-3-8-21-13-15/h3,5,8,13,16-18,25H,4,6-7,9-12,14H2,1-2H3,(H,22,26)(H,23,27)/t16-,17-,18+/m1/s1
InChIKeyIHGRXRHOBYYXJU-KURKYZTESA-N
XLogP0.11
TPSA103.79 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds10
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500392.50
LogP ≤ 50.11
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide?
The IUPAC name of N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide (CID 54640055) is N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide.
What is the SMILES notation for N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide?
The canonical SMILES for N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide is CN(C)CCCNC(=O)C[C@H]1CC[C@@H](NC(=O)Cc2cccnc2)[C@H](CO)O1.
What is the InChIKey of N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide?
The InChIKey is IHGRXRHOBYYXJU-KURKYZTESA-N. The full InChI is InChI=1S/C20H32N4O4/c1-24(2)10-4-9-22-19(26)12-16-6-7-17(18(14-25)28-16)23-20(27)11-15-5-3-8-21-13-15/h3,5,8,13,16-18,25H,4,6-7,9-12,14H2,1-2H3,(H,22,26)(H,23,27)/t16-,17-,18+/m1/s1.
What are the key properties of N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide?
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide has a molecular weight of 392.50 g/mol, XLogP of 0.11, 10 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]acetamide is sourced from PubChem (CID 54640055), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).